advertising
-
1.
Brooks GF, Carroll KC, Butel JS, et al: Jawetz, Melnick & Adelberg's Medical Microbiology, McGraw-Hill Medical, New York, 2007.
-
2.
Cardoso JC, Calonje E: Cutaneous manifestations of human papillomaviruses: a review. Acta Dermatovenerol Alp Panonica Adriat 20: 145, 2011.
-
3.
Fields BN, Knipe DM, Howley PM : Fields Virology, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2007.
-
4.
Bunney MH, Benton C, Cubie HA : Viral Warts: Biology and Treatment, 2nd Ed, Oxford University Press, Oxford, England, 1992.
-
5.
Barbosa P: Plantar verrucae and HIV infection. Clin Podiatr Med Surg 15: 317, 1998.
-
6.
Rubben A, Kalka K, Spelten B, et al: Clinical features and age distribution of patients with HPV 2/27/57-induced common warts. Arch Dermatol Res 289: 337, 1997.
-
7.
Chan SY, Chew SH, Egawa K, et al: Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology 239: 296, 1997.
-
8.
Johnston J, King CM, Shanks S, et al: Prevalence of plantar verrucae in patients with human immunodeficiency virus infection during the post-highly active antiretroviral therapy era. JAPMA 101: 35, 2011.
-
9.
Whitaker JM, Palefsky JM, Da Costa M, et al: Human papilloma virus type 69 identified in a clinically aggressive plantar verruca from an HIV-positive patient. JAPMA 99: 8, 2009.
-
10.
Davis MDP, Gostout BS, McGovern RM, et al: Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy. J Am Acad Dermatol 43: 340, 2000.
-
11.
Palefsky JM, Holly EA, Ralston ML, et al: Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177: 361, 1998.
-
12.
Morrison E, Goldberg G, Kadish A, et al: Polymerase chain reaction detection of human papillomavirus: quantitation may improve clinical utility. J Clin Microbiol 30: 2539, 1992.
-
13.
Aubin F, Gheit T, Pretet JL, et al: Presence and persistence of human papillomavirus types 1, 2, and 4 on emery boards after scraping off plantar warts. J Am Acad Dermatol 62: 151, 2010.
-
14.
Green M, Orth G, Wold WS, et al: Analysis of human cancers, normal tissues, and verruce plantares for DNA sequences of human papillomavirus types 1 and 2. Virology 110: 176, 1981.
-
15.
Tomson N, Sterling J, Ahmed I, et al: Human papillomavirus typing of warts and response to cryotherapy. J Eur Acad Dermatol Venereol 25: 1108, 2011.
-
16.
Porro AM, Alchorne MM, Mota GR, et al: Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1. Br J Dermatol 149: 1192, 2003.
-
17.
Kenyon E, Loveland L, Kilpatrick R, et al: Epidemiology of plantar verrucae in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 17: 94, 1998.
-
18.
Meberg R, Kenyon E, Bierman R, et al: Characterization of plantar verrucae among individuals with human immunodeficiency virus. JAPMA 88: 442, 1998.
-
19.
Soltani SK, Kenyon E, Barbosa P: Chronic and aggressive plantar verrucae in a patient with HIV. JAPMA 86: 555, 1996.
Human Papillomavirus Types 2, 27, and 57 Identified in Plantar Verrucae from HIV-Positive and HIV-Negative Individuals
Search for other papers by Christy M. King in
Current site
Google Scholar
PubMed
Search for other papers by James S. Johnston in
Current site
Google Scholar
PubMed
Search for other papers by Kene Ofili in
Current site
Google Scholar
PubMed
Search for other papers by Maylynn Tam in
Current site
Google Scholar
PubMed
Search for other papers by Joel Palefsky in
Current site
Google Scholar
PubMed
Search for other papers by Maria Da Costa in
Current site
Google Scholar
PubMed
Search for other papers by Yasha Mathur in
Current site
Google Scholar
PubMed
Search for other papers by Peter Barbosa in
Current site
Google Scholar
PubMed
Background
Although an increased prevalence of plantar verrucae has been associated with human immunodeficiency virus (HIV) infection, human papillomavirus (HPV) typing studies have not been published about this patient population. We sought to determine the prevalence of HPV types in plantar verrucae of HIV-positive (HIV+) and HIV-negative (HIV–) individuals.
Methods
Thirty-nine plantar verruca lesions in 17 individuals were examined. Nine participants were HIV+ and eight were HIV–. Detection of HPV was performed by polymerase chain reaction using two sets of primers: MY09/MY11. The type of HPV was determined by hybridization to 38 different HPV types. Clinical types of verrucae were correlated to the HPV strain identified in each lesion.
Results
Of the 39 plantar verruca samples, 38 typed to HPV-2, HPV-27, and HPV-57 strains in HIV+ and HIV– individuals. Specifically, a large proportion of the samples from HIV– individuals typed as HPV-27 (87.5%), and HPV-2 was the predominant type identified in HIV+ individuals (50%). No rare or atypical HPV types were found in either group. We identified HPV-2 and HPV-27 in 96% of verruca plantaris clinical type. Mosaic warts typed to HPV-27 and HPV-57, and 80% of punctate verrucae typed to HPV-57.
Conclusions
This study presents an increased prevalence of HPV-2, HPV-27, and HPV-57 in plantar verrucae in this study population and provides insight into the occurrence of these types in HIV+ and HIV– individuals.
advertising
